ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

REVB Revelation Biosciences Inc

2,35
0,00 (0,00%)
Avant marché
Dernière mise à jour : 10:00:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Revelation Biosciences Inc REVB NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,00 0,00% 2,35 10:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,35
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
22/3/202421:15BWRevelation Biosciences, Inc. Announces Financial Results for..
13/3/202414:00BWRevelation Biosciences Inc. Gives Oral Presentation at..
12/3/202414:00BWRevelation Biosciences Inc. to Participate in a Virtual..
04/3/202415:00BWRevelation Biosciences Inc. Announces Commencement of First..
14/2/202402:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202415:00BWRevelation Biosciences Inc. Receives Invitation to Give an..
12/2/202416:19EDGAR2Form SCHEDULE 13G/A - Statement of acquisition of beneficial..
08/2/202422:01EDGAR2Form 8-K - Current report
05/2/202422:41BWRevelation Biosciences Inc. Announces Closing of $6.2..
02/2/202422:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
01/2/202412:00BWRevelation Biosciences Inc. Announces Pricing of $6.2..
30/1/202423:21EDGAR2Form 8-K - Current report
30/1/202421:32EDGAR2Form S-1/A - General form for registration of securities..
30/1/202415:00BWRevelation Biosciences Inc. to Present at The International..
29/1/202423:32EDGAR2Form S-1/A - General form for registration of securities..
23/1/202422:18EDGAR2Form 8-K - Current report
23/1/202415:00BWRevelation Biosciences Inc. Announces 1-for-30 Reverse Stock..
22/1/202422:01EDGAR2Form 8-K - Current report
22/12/202323:06EDGAR2Form DEF 14A - Other definitive proxy statements
22/12/202319:23EDGAR2Form S-1 - General form for registration of securities under..
12/12/202322:59EDGAR2Form PRE 14A - Other preliminary proxy statements
13/11/202322:30EDGAR2Form 8-K - Current report
13/11/202322:05BWRevelation Biosciences, Inc. Announces Financial Results for..
09/11/202322:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/10/202322:26EDGAR2Form 8-K - Current report
12/10/202315:00BWGemini Induces Pharmacologic Activity and Related..
04/10/202315:00BWRevelation Biosciences, Inc. to Present at the 2023 ROTH..
02/10/202322:24EDGAR2Form 8-K - Current report
02/10/202315:00BWRevelation Biosciences Inc. Announces Appointment of Lakhmir..
11/8/202322:30EDGAR2Form 8-K - Current report
11/8/202322:25EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/8/202322:10BWRevelation Biosciences Inc. Announces Financial Results for..
11/8/202322:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202322:05EDGAR2Form 8-K - Current report
14/7/202322:51EDGAR2Form 8-K - Current report
07/7/202322:09EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07/7/202322:07EDGAR2Form 8-K - Current report
29/6/202322:23EDGAR2Form 8-K - Current report
29/6/202315:00BWREMINDER: Revelation Biosciences, Inc. Urges All..
12/6/202322:15BWRevelation Biosciences Inc. Announces Adjournment of 2023..
22/5/202315:00BWRevelation Biosciences Inc. Announces Financial Results for..

Dernières Valeurs Consultées

Delayed Upgrade Clock